Abstract:The inappropriate retention of neutrophils at inflammatory sites is a major driver of the excessive tissue damage characteristic of respiratory inflammatory diseases including COPD, ARDS, and cystic fibrosis. The molecular programmes which orchestrate neutrophil recruitment to inflammatory sites through chemotactic guidance have been well-studied. However, how neutrophil sensitivity to these cues is modulated during inflammation resolution is not understood. The identification of neutrophil reverse migration as a mechanism of inflammation resolution and the ability to modulate this therapeutically has identified a new target to treat inflammatory disease. Here we investigate the role of the CXCL12/CXCR4 signaling axis in modulating neutrophil retention at inflammatory sites. We used an in vivo tissue injury model to study neutrophilic inflammation using transgenic zebrafish larvae. Expression of cxcl12a and cxcr4b during the tissue damage response was assessed using in situ hybridization and analysis of RNA sequencing data. CRISPR/Cas9 was used to knockdown cxcl12a and cxcr4b in zebrafish larvae. The CXCR4 antagonist AMD3100 was used to block the Cxcl12/Cxcr4 signaling axis pharmacologically. We identified that cxcr4b and cxcl12a are expressed at the wound site in zebrafish larvae during the inflammatory response. Following tail-fin transection, removal of neutrophils from inflammatory sites is significantly increased in cxcr4b and cxcl12a CRISPR knockdown larvae. Pharmacological inhibition of the Cxcl12/Cxcr4 signaling axis accelerated resolution of the neutrophil component of inflammation, an effect caused by an increase in neutrophil reverse migration. The findings of this study suggest that CXCR4/CXCL12 signaling may play an important role in neutrophil retention at inflammatory sites, identifying a potential new target for the therapeutic removal of neutrophils from the lung in chronic inflammatory disease.

Altered CXCR2 signaling in beta-arrestin-2-deficient mouse models.

Altered CXCR2 Signaling in β-Arrestin-2-Deficient Mouse Models

The Chemokine Receptors CXCR1 and CXCR2 Couple to Distinct G Protein-Coupled Receptor Kinases To Mediate and Regulate Leukocyte Functions

Genetic Ablation of CXCR2 Protects Against Cigarette Smoke-Induced Lung Inflammation and Injury.

Β-Arrestin2 is Critically Involved in CXCR4-mediated Chemotaxis, and This is Mediated by Its Enhancement of P38 MAPK Activation

C5aR2 Deficiency Lessens C5aR1 Distribution and Expression in Neutrophils and Macrophages

Impaired healing of nitrogen mustard wounds in CXCR2 null mice.

Mechanism Of Cxc Chemokine Ligand 5 (Cxcl5)/Cxc Chemokine Receptor 2 (Cxcr2) Bio-Axis In Mice With Acute Respiratory Distress Syndrome

CXCL17 is a proinflammatory chemokine and promotes neutrophil trafficking

The CXCL12/CXCR4 Signaling Axis Retains Neutrophils at Inflammatory Sites in Zebrafish

CX3CR1 Positively Regulates BCR Signaling Coupled with Cell Metabolism Via Negatively Controlling Actin Remodeling

Absence of the Non-Signalling Chemerin Receptor CCRL2 Exacerbates Acute Inflammatory Responses In Vivo

Cannabinoid receptor 2 deficiency exacerbates inflammation and neutrophil recruitment

Platelet CXCL7 and CXCL4 inhibit chemokine scavenging and improve innate immunity to bacterial infection (P1317)

β-Arrestin1 and β-Arrestin2 Are Required to Support the Activity of the CXCL12/HMGB1 Heterocomplex on CXCR4

Depletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer

Characterization of a Novel Mouse Model with Genetic Deletion of CD177

CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-β

Ccr2 Inhibition Sequesters Multiple Subsets of Leukocytes in the Bone Marrow

Chemerin attracts neutrophil reverse migration by interacting with C–C motif chemokine receptor-like 2

Host Cxcr2-Dependent Regulation of Pancreatic Cancer Growth, Angiogenesis, and Metastasis